Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019

Blood Cancer J. 2022 Apr 7;12(4):54. doi: 10.1038/s41408-022-00656-y.

Eiji Kusumi¹, Anju Murayama^{2

3}, Sae Kamamoto^{4

5}, Moe Kawashima^{4

6}, Makoto Yoshida⁴, Hiroaki Saito⁷, Toyoaki Sawano⁸, Erika Yamashita⁴, Tetsuya Tanimoto⁹, Akihiko Ozaki^{4

10}

¹ Department of Internal Medicine, Navitas Clinic Shinjuku, Shinjuku-ku, Tokyo, Japan.
² Medical Governance Research Institute, Minato-ku, Tokyo, Japan. [email protected].
³ Tohoku University School of Medicine, Sendai City, Miyagi, Japan. [email protected].
⁴ Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
⁵ Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
⁶ Fukushima Medical University, Fukushima City, Fukushima, Japan.
⁷ Department of Gastroenterology, Sendai Kosei Hospital, Sendai City, Miyagi, Japan.
⁸ Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Fukushima, Japan.
⁹ Department of Internal Medicine, Navitas Clinic, Tachikawa City, Tokyo, Japan.
¹⁰ Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Fukushima, Japan.

No abstract available

Publication types